Daniel J Baillache

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Tyrosine Kinase

Top Venues

RSC medicinal chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel J Baillache, Teresa Valero, Álvaro Lorente-Macías, David Jonathan Bennett, Richard J R Elliott, Neil O Carragher, Asier Unciti-Broceta
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells. RSC medicinal chemistry 14 (12) (2023)
Daniel J Baillache, Teresa Valero, Álvaro Lorente-Macías, David Jonathan Bennett, Richard J R Elliott, Neil O Carragher, Asier Unciti-Broceta
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells. RSC medicinal chemistry 14 (12) (2023)
Daniel J Baillache, Teresa Valero, Álvaro Lorente-Macías, David Jonathan Bennett, Richard J R Elliott, Neil O Carragher, Asier Unciti-Broceta
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells. RSC medicinal chemistry 14 (12) (2023)
Catherine Adam, Thomas L Bray, Ana M Perez-Lopez, Ee Hong Tan, Belén Rubio-Ruiz, Daniel J Baillache, Douglas R Houston, Mark J Salji, Hing Y Leung, Asier Unciti-Broceta
A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo . Journal of medicinal chemistry 65 (1) (2022)
Cecilia C Ayala-Aguilera, Teresa Valero, Álvaro Lorente-Macías, Daniel J Baillache, Stephen Croke, Asier Unciti-Broceta
Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis. Journal of medicinal chemistry (2021)
Daniel J Baillache, Asier Unciti-Broceta
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold. RSC medicinal chemistry 11 (10) (2020)